Clocinnamox
Names | |
---|---|
IUPAC name
(E)-N-[(4R,4aS,7aR,12bR)-3-(Cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-chlorophenyl)prop-2-enamide | |
Other names
Chlorocinnamoylaminodihydronormorphinone | |
Identifiers | |
ChEMBL | ChEMBL386492 |
ChemSpider | 5022878 |
| |
Jmol-3D images | Image |
PubChem | 6540640 |
| |
Properties | |
Molecular formula |
C29H29ClN2O4 |
Molar mass | 505.00 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Clocinnamox is a selective, irreversible μ-opioid receptor antagonist.[1]
References
- ↑ Filho, CB; Del Fabbro, L; De Gomes, MG; Goes, AT; Souza, LC; Boeira, SP; Jesse, CR (2013). "Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test". European journal of pharmacology 698 (1–3): 286–91. doi:10.1016/j.ejphar.2012.11.003. PMID 23178563.